Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dioxins | 11 | 2022 | 102 | 2.730 |
Why?
|
| Polychlorinated Biphenyls | 10 | 2022 | 245 | 2.370 |
Why?
|
| Environmental Pollutants | 12 | 2023 | 1180 | 2.200 |
Why?
|
| Diethylhexyl Phthalate | 2 | 2023 | 81 | 1.680 |
Why?
|
| Hydrocarbons, Chlorinated | 7 | 2020 | 128 | 1.420 |
Why?
|
| Russia | 24 | 2022 | 409 | 1.270 |
Why?
|
| Phthalic Acids | 2 | 2023 | 436 | 1.250 |
Why?
|
| Pesticides | 6 | 2020 | 287 | 1.120 |
Why?
|
| Environmental Exposure | 14 | 2023 | 4231 | 1.060 |
Why?
|
| Lead | 9 | 2022 | 854 | 1.010 |
Why?
|
| Sexual Maturation | 5 | 2019 | 265 | 0.900 |
Why?
|
| Puberty | 9 | 2019 | 489 | 0.750 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 5 | 2011 | 546 | 0.590 |
Why?
|
| Body Composition | 2 | 2019 | 2400 | 0.450 |
Why?
|
| Body Height | 2 | 2017 | 1574 | 0.440 |
Why?
|
| Semen | 3 | 2022 | 316 | 0.330 |
Why?
|
| Chromatography, Liquid | 2 | 2023 | 977 | 0.330 |
Why?
|
| Growth | 1 | 2010 | 376 | 0.330 |
Why?
|
| Hexachlorobenzene | 3 | 2015 | 30 | 0.290 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2023 | 1157 | 0.280 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2007 | 186 | 0.280 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 3 | 2015 | 88 | 0.280 |
Why?
|
| Child | 30 | 2022 | 77478 | 0.260 |
Why?
|
| Furans | 4 | 2021 | 194 | 0.250 |
Why?
|
| Endocrine Disruptors | 2 | 2018 | 237 | 0.240 |
Why?
|
| Androgen Antagonists | 2 | 2023 | 1350 | 0.240 |
Why?
|
| Hypotension | 1 | 2009 | 880 | 0.220 |
Why?
|
| Diet Surveys | 1 | 2007 | 1172 | 0.220 |
Why?
|
| Insulin Resistance | 1 | 2014 | 3861 | 0.190 |
Why?
|
| Child Development | 1 | 2011 | 2222 | 0.180 |
Why?
|
| Benzofurans | 2 | 2011 | 140 | 0.180 |
Why?
|
| Adolescent | 17 | 2023 | 85649 | 0.170 |
Why?
|
| Prospective Studies | 14 | 2022 | 53187 | 0.170 |
Why?
|
| Nutritional Status | 1 | 2007 | 1606 | 0.160 |
Why?
|
| Male | 34 | 2023 | 349538 | 0.160 |
Why?
|
| Longitudinal Studies | 7 | 2019 | 13921 | 0.150 |
Why?
|
| Lung Diseases | 1 | 2007 | 1884 | 0.140 |
Why?
|
| Epidemiologic Studies | 1 | 2019 | 676 | 0.130 |
Why?
|
| Electric Impedance | 1 | 2019 | 727 | 0.130 |
Why?
|
| Disease Outbreaks | 1 | 2005 | 1768 | 0.130 |
Why?
|
| Spermatozoa | 1 | 2018 | 625 | 0.120 |
Why?
|
| Cohort Studies | 8 | 2022 | 40450 | 0.110 |
Why?
|
| Humans | 38 | 2023 | 742088 | 0.110 |
Why?
|
| Linear Models | 4 | 2013 | 5948 | 0.100 |
Why?
|
| Immunoglobulins, Intravenous | 3 | 2011 | 657 | 0.090 |
Why?
|
| Body Mass Index | 4 | 2019 | 12695 | 0.090 |
Why?
|
| Semen Analysis | 2 | 2022 | 204 | 0.090 |
Why?
|
| Puberty, Delayed | 1 | 2010 | 115 | 0.090 |
Why?
|
| Young Adult | 10 | 2023 | 56350 | 0.080 |
Why?
|
| Health Surveys | 3 | 2010 | 4030 | 0.080 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2010 | 425 | 0.080 |
Why?
|
| Lead Poisoning | 1 | 2010 | 304 | 0.080 |
Why?
|
| Triglycerides | 1 | 2014 | 2450 | 0.070 |
Why?
|
| Leptin | 1 | 2014 | 1593 | 0.070 |
Why?
|
| Body Weight | 1 | 2017 | 4664 | 0.070 |
Why?
|
| Cholesterol | 1 | 2014 | 2895 | 0.070 |
Why?
|
| Fever | 2 | 2011 | 1612 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 2014 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2014 | 6452 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2018 | 4282 | 0.060 |
Why?
|
| Bronchial Provocation Tests | 1 | 2003 | 227 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2011 | 12242 | 0.060 |
Why?
|
| Procarbazine | 1 | 2022 | 181 | 0.060 |
Why?
|
| Food | 1 | 2007 | 769 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2011 | 14720 | 0.050 |
Why?
|
| Canada | 1 | 2007 | 2061 | 0.050 |
Why?
|
| Logistic Models | 4 | 2011 | 13403 | 0.050 |
Why?
|
| Sputum | 1 | 2003 | 474 | 0.050 |
Why?
|
| Sperm Count | 1 | 2022 | 216 | 0.050 |
Why?
|
| Sperm Motility | 1 | 2022 | 253 | 0.050 |
Why?
|
| Japan | 1 | 2005 | 1360 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2010 | 1575 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2011 | 2924 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2014 | 6249 | 0.040 |
Why?
|
| Time Factors | 2 | 2016 | 40054 | 0.040 |
Why?
|
| Insulin | 1 | 2014 | 6575 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 39004 | 0.040 |
Why?
|
| Luteinizing Hormone | 1 | 2022 | 864 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2011 | 2407 | 0.040 |
Why?
|
| Antioxidants | 1 | 2007 | 1659 | 0.040 |
Why?
|
| Seasons | 1 | 2005 | 1492 | 0.040 |
Why?
|
| Adult | 8 | 2023 | 213712 | 0.040 |
Why?
|
| Vitamins | 1 | 2007 | 1608 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2010 | 2024 | 0.040 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2007 | 1341 | 0.040 |
Why?
|
| Critical Care | 1 | 2009 | 2640 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2009 | 5978 | 0.030 |
Why?
|
| Child, Preschool | 4 | 2011 | 40955 | 0.030 |
Why?
|
| Coronary Aneurysm | 2 | 2010 | 237 | 0.030 |
Why?
|
| Anthropometry | 1 | 2019 | 1350 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2885 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2003 | 1178 | 0.030 |
Why?
|
| Reproduction | 1 | 2019 | 668 | 0.030 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2013 | 81 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2019 | 1726 | 0.030 |
Why?
|
| Infant | 3 | 2011 | 35070 | 0.030 |
Why?
|
| Luminescence | 1 | 2013 | 137 | 0.030 |
Why?
|
| Bacteria | 1 | 2003 | 2102 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2011 | 12344 | 0.030 |
Why?
|
| Environmental Monitoring | 1 | 2018 | 1413 | 0.020 |
Why?
|
| Female | 10 | 2019 | 379592 | 0.020 |
Why?
|
| Geography | 1 | 2013 | 669 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 405 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2012 | 302 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2011 | 361 | 0.020 |
Why?
|
| Milk | 1 | 2013 | 449 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2010 | 235 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2010 | 25575 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 2795 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2012 | 577 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2010 | 570 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2008 | 211 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2019 | 3278 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 461 | 0.020 |
Why?
|
| Incidence | 1 | 2005 | 20928 | 0.020 |
Why?
|
| Age Factors | 2 | 2015 | 18355 | 0.020 |
Why?
|
| California | 1 | 2010 | 1400 | 0.020 |
Why?
|
| Emergency Treatment | 1 | 2010 | 517 | 0.020 |
Why?
|
| Educational Status | 1 | 2013 | 2533 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2010 | 7770 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 2970 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 7153 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2013 | 1339 | 0.020 |
Why?
|
| Trauma Centers | 1 | 2010 | 889 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2009 | 62966 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2019 | 9144 | 0.020 |
Why?
|
| Pregnancy | 2 | 2019 | 29087 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 24913 | 0.010 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2003 | 110 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 331 | 0.010 |
Why?
|
| Gestational Age | 1 | 2011 | 3490 | 0.010 |
Why?
|
| Risk Factors | 1 | 2009 | 72145 | 0.010 |
Why?
|
| Coronary Thrombosis | 1 | 2004 | 494 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6365 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2010 | 1760 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 10943 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2003 | 1104 | 0.010 |
Why?
|
| Steroids | 1 | 2004 | 931 | 0.010 |
Why?
|
| United States | 1 | 2007 | 69693 | 0.010 |
Why?
|
| Recurrence | 1 | 2011 | 8333 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 2271 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2010 | 3187 | 0.010 |
Why?
|
| Algorithms | 2 | 2010 | 13853 | 0.010 |
Why?
|
| Diet | 1 | 2013 | 7923 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 2276 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15494 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2004 | 4567 | 0.010 |
Why?
|
| Aspirin | 1 | 2004 | 3278 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 7276 | 0.010 |
Why?
|
| Echocardiography | 1 | 2004 | 5097 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2004 | 2789 | 0.010 |
Why?
|
| Aging | 1 | 2010 | 8626 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 20086 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2004 | 23320 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2010 | 77098 | 0.000 |
Why?
|
| Animals | 1 | 2013 | 168561 | 0.000 |
Why?
|
| Middle Aged | 1 | 2010 | 213127 | 0.000 |
Why?
|
Concepts
(157)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_